Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mercuric chloride (HgCl2), also known as mercury(II) chloride or corrosive sublimate, is a highly toxic inorganic compound composed of mercury and chlorine. It appears as a white crystalline solid and was historically used as a topical antiseptic and disinfectant due to its strong antimicrobial properties. In the past, it was also used in the treatment of syphilis but has been abandoned for medicinal use because of its severe toxicity and the availability of safer alternatives. Mercuric chloride acts by denaturing proteins through binding to sulfhydryl groups, leading to cellular dysfunction and death. Today it is primarily used as an industrial reagent or catalyst rather than in medicine[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mercuric chloride.